|
Market Closed -
OTC Markets
20:08:25 10/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 5.010 USD | +0.20% |
|
-.--% | +0.20% |
| 14/03/14 | Pegasus Pharmaceuticals Develops Natural All-Purpose Cleaner/Degreaser | CI |
| 28/01/14 | Pegasus Pharmaceuticals Develops and Completes Testing of MoldGuardian a New Anti-Fungi Product | CI |
| 21/12/21 | Pegasus Pharmaceuticals : Quarterly Report | PU |
| 1 day | +0.20% | ||
| 3 months | +0.20% | ||
| 6 months | +0.20% | ||
| Current year | +0.20% |
| Current year | 5 |  | 5.01 |
| 1 year | 5 | | 5.01 |
| 3 years | 1.02 | | 23 |
| 5 years | 1.02 | | 89.7 |
| 10 years | 1 | | 148.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Samuel Eisenberg
CEO | Chief Executive Officer | - | 12/10/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Samuel Eisenberg
BRD | Director/Board Member | - | 12/10/2021 |
Employees
-
Sector
-
- Stock Market
- Stocks
- DVTC Stock
Select your edition
All financial news and data tailored to specific country editions
